2004
DOI: 10.1159/000080963
|View full text |Cite
|
Sign up to set email alerts
|

Decreased Release of the Angiogenic Peptide Vascular Endothelial Growth Factor in Alzheimer’s Disease: Recovering Effect with Insulin and DHEA Sulfate

Abstract: Changes of vascular endothelial growth factor (VEGF) secretion have recently been demonstrated in patients with Alzheimer’s disease (AD). Since VEGF has been involved in brain angiogenesis, neuroprotection and cerebromicrovascular exchange of substrates and nutrients, the study of VEGF could have important relapses into the pathogenesis and treatment of AD. Within this context, 35 healthy subjects (16 of young and 19 of old age), 18 patients with dementia of the vascular type (VAD) and 22 with dementia of the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
28
0

Year Published

2006
2006
2022
2022

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 39 publications
(29 citation statements)
references
References 84 publications
1
28
0
Order By: Relevance
“…A recent study demonstrated a decreased release of VEGF in AD (Solerte et al, 2005). However, in other studies, increased VEGF expression was demonstrated in AD and VAD (Pogue and Lukiw 2004;Tarkowski et al, 2002).…”
Section: Fig (5)mentioning
confidence: 87%
“…A recent study demonstrated a decreased release of VEGF in AD (Solerte et al, 2005). However, in other studies, increased VEGF expression was demonstrated in AD and VAD (Pogue and Lukiw 2004;Tarkowski et al, 2002).…”
Section: Fig (5)mentioning
confidence: 87%
“…It has been proposed that the increase in VEGF expression levels occurs as a secondary response to hypoperfusion and hypoxia in the AD brain. Nonetheless, a reduction of VEGF has also been described in peripheral immune cells of Alzheimer patients, an observation explained by the toxic effects of -amyloid on VEGF expression [101]. Therefore, the role of VEGF in Alzheimer's is considered hypothetical and further studies are needed.…”
Section: Angioglioneurin Administrationmentioning
confidence: 99%
“…Recent groundbreaking research reported the recent discovery of a decreased secretion and release of VEGF in the supernatants of circulating natural killer (NK) immune cells in patients with AD compared to normal controls and patients with other types of senile dementias [90]. These findings become even more significant if, as these authors suggest, the importance of VEGF in brain angiogenesis, neuroprotection and cerebrovascular exchange of nutrients is taken into account.…”
Section: Iii) Potential Therapeutic Application Of Human Growth Factomentioning
confidence: 99%